STOCK TITAN

Recursion (NASDAQ: RXRX) director sale under Rule 10b5-1 trading plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Recursion Pharmaceuticals director Christopher Gibson converted and sold shares of the company’s stock. On April 7, he converted 40,000 shares of Class B Common Stock into 40,000 shares of Class A Common Stock and then sold 40,000 Class A shares at $3.10 per share in an open-market transaction.

The trades were made pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2025. Following these transactions, he directly holds 906,556 shares of Class A Common Stock and 4,443,334 shares of Class B Common Stock, while various family entities no longer show Class B holdings in this filing.

Positive

  • None.

Negative

  • None.
Insider Gibson Christopher
Role Director
Sold 40,000 shs ($124K)
Type Security Shares Price Value
Conversion Class B Common Stock 40,000 $0.00 --
Conversion Class A Common Stock 40,000 $0.00 --
Sale Class A Common Stock 40,000 $3.10 $124K
holding Class B Common Stock -- -- --
holding Class B Common Stock -- -- --
holding Class B Common Stock -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
Holdings After Transaction: Class B Common Stock — 4,443,334 shares (Direct); Class A Common Stock — 946,556 shares (Direct); Class B Common Stock — 0 shares (Indirect, by LAHWRAN-3 LLC); Stock Option (Right to Buy) — 0 shares (Direct)
Footnotes (1)
  1. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Shares sold 40,000 shares Class A Common Stock sold at $3.10 on April 7, 2026
Sale price $3.10 per share Open-market sale of 40,000 Class A shares
Class A holdings after 906,556 shares Direct Class A Common Stock held post-transaction
Class B holdings after 4,443,334 shares Direct Class B Common Stock held post-conversion
Conversion amount 40,000 shares Class B converted into Class A Common Stock
Option strike price $7.25 per share Stock option to buy Class A shares expiring February 3, 2035
Option strike price $10.09 per share Stock option to buy Class A shares expiring February 9, 2034
Option strike price $2.48 per share Stock option to buy Class A shares expiring December 30, 2030
Rule 10b5-1 trading plan financial
"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Class B Common Stock financial
"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder."
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Class A Common Stock financial
"underlying_security_title: "Class A Common Stock" and sales of 40,000 shares of Class A Common Stock at $3.1000 per share."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
derivative security financial
"transaction_code_description: "Conversion of derivative security" for the Class B to Class A conversion."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" with various exercise prices and expiration dates."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gibson Christopher

(Last)(First)(Middle)
C/O RECURSION PHARMACEUTICALS
41 S. RIO GRANDE STREET

(Street)
SALT LAKE CITY UTAH 84101

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RECURSION PHARMACEUTICALS, INC. [ RXRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock04/07/2026C(1)(2)40,000A$0946,556D
Class A Common Stock04/07/2026S(2)40,000D$3.1906,556D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock$0(1)04/07/2026C(1)40,000 (1) (1)Class A Common Stock40,000$04,443,334D
Class B Common Stock$0 (1) (1)Class A Common Stock0386,000Iby LAHWRAN-3 LLC(3)
Class B Common Stock$0 (1) (1)Class A Common Stock0388,000Iby LAHWRAN-4 LLC(4)
Class B Common Stock$0 (1) (1)Class A Common Stock050,000Iby Gibson Family Trust(5)
Stock Option (Right to Buy)$7.25 (6)02/03/2035Class A Common Stock01,050,567D
Stock Option (Right to Buy)$10.09 (7)02/09/2034Class A Common Stock0666,898D
Stock Option (Right to Buy)$8.55 (8)02/01/2033Class A Common Stock0813,600D
Stock Option (Right to Buy)$11.4 (9)02/04/2032Class A Common Stock0399,002D
Stock Option (Right to Buy)$11.402/04/202202/04/2032Class A Common Stock05,436D
Stock Option (Right to Buy)$2.48 (10)12/30/2030Class A Common Stock0282,500D
Explanation of Responses:
1. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
2. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
3. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
4. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
5. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
6. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
7. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
8. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
9. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
10. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Remarks:
/s/Jonathan Golightly, attorney-in-fact04/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did RXRX director Christopher Gibson report?

Christopher Gibson reported a planned conversion and sale of RXRX shares. He converted 40,000 Class B shares into 40,000 Class A shares, then sold 40,000 Class A shares at $3.10 each, while retaining substantial remaining holdings in both Class A and Class B stock.

How many Recursion Pharmaceuticals (RXRX) shares did the director sell?

The director sold 40,000 shares of Class A Common Stock. These shares were sold on April 7 at $3.10 per share after a one-for-one conversion from Class B stock, as part of an open-market transaction disclosed in the insider filing.

Was the RXRX insider sale made under a Rule 10b5-1 trading plan?

Yes, the sale was made under a Rule 10b5-1 trading plan. A footnote states the transaction occurred pursuant to a Rule 10b5-1 plan adopted by Christopher Gibson on May 12, 2025, indicating the trades were pre-arranged rather than opportunistic.

What RXRX holdings does Christopher Gibson report after these transactions?

After the transactions, Gibson reports large remaining positions. He directly owns 906,556 shares of Class A Common Stock and 4,443,334 shares of Class B Common Stock, according to the post-transaction balances shown in the filing’s ownership tables.

What is the relationship between RXRX Class B and Class A Common Stock in this filing?

Each Class B share is convertible into one Class A share. A footnote explains that every share of Class B Common Stock can be converted into a single Class A share at the holder’s option, with no expiration date on this conversion right.

Does Christopher Gibson still hold RXRX stock options after this Form 4?

The filing lists several remaining stock option positions. It shows options to buy Class A shares with exercise prices including $7.25, $8.55, $10.09, $11.40 and $2.48, and expiration dates ranging from 2030 through 2035, reflecting ongoing equity-based incentives.